SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma settles Modafinil antitrust litigation matter in US with certain plaintiffs

27 Nov 2018 Evaluate

Sun Pharmaceutical Industries and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in the In re Modafinil Antitrust Litigation matter pending in the United States District Court for the Eastern District of Pennsylvania. The settlements extend to all claims brought by the Direct Purchaser Plaintiffs. The terms of the settlements are confidential.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1681.20 13.20 (0.79%)
21-Apr-2026 09:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.20
Dr. Reddys Lab 1227.10
Cipla 1229.10
Zydus Lifesciences 932.05
Lupin 2333.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×